|
Market Cap (2-Jul) $205,017,904 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (19-Jun) 40,298 (0.02%) (504th) |
|
52w High $1.97 |
52w Low $0.92 |
P/E - |
EPS -0.05 |
RAC released this announcement to the ASX on 30 March 2021, 9:29. The announcement is marked as price sensitive, and is 3 page(s) in length and 112.93kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.009% short sold according to ASIC data. It was ranked the 597th most shorted stock on the ASX. It is now ranked as the 504th most shorted stock on the ASX with 0.023% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Race Initiates Extramedullary AML Preclinical Study | 30 March 2021, 9:29 |
| Race Initiates FTO Directed Kidney Cancer Preclinical Study | 25 March 2021, 9:29 |
| Race Initiates FTO Melanoma Preclinical Study | 19 March 2021, 9:33 |
| Change in substantial holding | 15 March 2021, 10:50 |
You must be logged in to post a reply.
Race Oncology 